Biopharma Company GSK and BU Collaborate on Lung Disease Treatments
A new collaboration between the global biopharma giant and researchers from BU’s Center for Regenerative Medicine (CReM) and Boston Medical Center could bring hope to millions around the world with lung diseases. Together, they aim to use CReM-developed lung cells to better understand pulmonary fibrosis and identify new ways to halt or slow the progression of this and other lung diseases.
